3D Cell Culture Market to reach 6.47 billion in 2030 with a CAGR of around 16.3%

According to Strategic Market Research, 3D cell culture market was worth USD 1.43 billion in 2020 and is likely to reach a landmark of nearly USD 6.47 billion in 2030 with a robust CAGR of 16.3%. Need to Focus on the development of alternative options in animal testing and Microfluidics based 3D cell culture to boost the 3d cell culture industry.

Sambalpur, INDIA

New York, United States, June 07, 2022 (GLOBE NEWSWIRE) -- 3D cell culture is regarded as an artificially created environment where the biological cells are allowed to grow or interact with their respective surroundings in all three dimensions. In terms of technology, scaffold-based technology had the largest revenue share of more than about 68.96 % in 2020 and it is estimated to maintain its dominance all over the forecasted period of 2020-2030. Moreover, on a regional basis, North America dominated the total 3D Cell Culture Market in 2020, possessing a revenue share of more than 43 %. However, the APAC region is prevised to witness the fastest CAGR within the regional market from 2020 to 2030.

To get a first-hand overview of the report, Request a Sample at 


The segmentation outlook of the latest report published by Strategic Market Research on 3D Cell Culture Market is as follows:

Based on Technology

  • Scaffold-based
    • Hydrogels
    • Polymeric Scaffolds
    • Micro-patterned Surface Microplates
    • Nanofiber-based Scaffolds
  • Scaffold-free
    • Hanging Drop Microplates
    • Microfluidic 3D Cell Culture
    • Spheroid Microplates with ULA coating
    • Magnetic Levitation & 3D Bioprinting
  • Bioreactors

Based on Application

  • Cancer
  • Tissue Engineering & Immunohistochemistry
  • Drug Development
  • Stem Cell Research
  • Others

Based on End-User

  • Biotechnology and Pharmaceutical Industries
  • Research Laboratories and Institutes
  • Hospitals and Diagnostic Centers
  • Others


  • North America
  • Europe
  • Asia-Pacific

Make a Direct Purchase of the latest Nanodiamonds Market Report published in the month of January 2022. Click the below link to initiate the purchase: 


The 3D Cell Culture Market is poised to reach a market value of USD 6.47 billion by 2030 from USD 1.43 billion in 2020, at a CAGR of 16.3 % during the forecasted period. Growth in this 3D Cell Culture market is primarily driven by the rise in the focus on new upcoming alternatives for animal testing, increase in the focus on personalized medicine, growing occurence of chronic diseases, and the wide availability of funding for the research purposes. The high utility of 3D models for research purposes about Covid-19 as well as respiratory diseases is prevised to provide massive growth opportunities to the 3D Cell Culture market. Several other vital parameters amplifying the market growth include the introduction of new products and the broad applications of 3D protocols in the field of biological researches.

By Technology, the scaffold-based technology segment held the largest share of the 3D Cell Culture Market.

In terms of technology, scaffold-based technology had the largest revenue share of more than 68.96 % in 2020. Furthermore, surge in the demand for scaffold-based technology and the rise in the awareness of nanotechnology in the field of biomedical research and its vast applications is prevised to provide ample opportunities for the growth of the segment. The National Institutes of Health declared an investment of around USD 445 Million in nanomedicine in the year 2020. In addition, the National Nanotechnology Initiative got more than USD 1.7 Billion in funding in the year 2021, which in turn will foster the expansion of the 3D cell culture scaffold market.

By Application, the Cancer segment possessed the highest share of the 3D Cell Culture Market.

In terms of Application, the Cancer market segment possessed the maximum portion of the total 3D Cell Culture Market share, accounting for about 24.56 % of the total market revenue, and is previse to expand at a CAGR of 15.4 % in 2020. Growing R&D activities by utilizing spheroids as model systems to create anti-cancer treatments and the rise in the usage of 3-dimensional cellular models are the key drivers that are amplifying the growth of this market segment. As per The National Cancer Institute, it is reported that there were 16.9 million cancer survivors in USA in the year 2020, and by the end of the year 2030, the total number of cancer survivors is projected to reach a landmark of 22.2 million. Furthermore, from 2021 to 2030, the stem cell research market segment is prevised to expand at the fastest CAGR throughout the forecasted timeframe.

By End-User, the Biotechnology and Pharmaceutical industries dominated the entire 3D Cell Culture Market.

In terms of End-user, the entire market is segregated into Biotechnology & Pharmaceutical Industries, Research Laboratories and Institutes, Hospitals and Diagnostic Centers, and Others. Among these segments, the biotechnology and pharmaceutical industries category held the largest revenue share of more than 46% in the year 2020. In comparison to 2D cell culture, the 3D cell culture possesses a wide variety of benefits and advantages in terms of supplying appropriate oxygen content and nutritional gradients and helps to better understand various cell functions like adhesion, proliferation, morphology, viability, microenvironment, and response to drugs. These are some of the key factors that are driving the segment’s growth.

North America held a significant portion of the 3D Cell Culture Market share.

By Region, North America dominated the total 3D Cell Culture Market in 2020, possessing a revenue share of more than 43 %. It is also anticipated that the North American region will maintain its dominance throughout the projected period due to the factors like rise in the private and state financial support for building advanced 3D cell culture models, rise in the healthcare expenditures, and the growing number of research institutes and universities. For example, Inventia Life Science, a global leader in advanced 3D cell culture for clinical and research purposes, has declared the closure of a USD 25 Million Series B funding round which was led by Blackbird Ventures. On the other hand, the APAC/Asia- Pacific region is prevised to witness the fastest CAGR within the regional market from 2021 to 2030. It is primarily due to the rising investments by various multinational corporations in the entire region. 

Before initiating a purchase, make a Pre-order inquiry and get a detailed overview of the content of the report.

Pertinent players that are covered in the Global 3D Cell Culture Market report are:

  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • PromoCell GmbH
  • Greiner Bio One International GmbH
  • Corning, Inc.
  • 3D Biomatrix
  • Lonza
  • Avantor Performance Materials, LLC
  • Tecan Trading AG
  • 3D Biotek LLC
  • Global Cell Solutions, Inc.
  • InSphero

Kindly go through and get access to our comprehensive coverage of a myriad number of Healthcare reports published in the last three months: 

Recent Developments related to Global 3D Cell Culture Market:

  • On the 15th of December 2021, BOSTON, Mass., the R&D Data Cloud company, stated that CellPort Software, a SaaS company that digitizes workflows for cell development and manufacturing, has joined the Tetra Partner Network (TPN) to boost the speed of the delivery of cell-based therapeutics.
  • On 11th of January 2021, Adocia, a clinical-stage biopharmaceutical company focused on diabetes treatment and other metabolic diseases with innovative formulations of proteins and peptides, declared that it is building a hydrogel scaffold that especially protects and hosts pancreatic β cells for the replacement of the missing cells of the patients with type 1 diabetes.
  • On the 8th of December 2020, eNuvio located in Montreal, Canada declared the launch of the 1st completely reusable 3D cell culture microplate in the market called the EB-Plate. Currently, scientific research studies consume a significant volume of single-use plastics, especially from pipette tips and serological pipettes for vials and culture microplates.

Related Reports

Live Cell Imaging Market

The crucial report on “Live Cell Imaging Market” Insights & Forecast 2030 published by Strategic Market Research offers a concrete understanding of the significant market insights. The market was valued at 1.8 Billion in 2020, and it's prevised to reach up to 4.18 Billion by 2030 with a CAGR of 8.8%. The rise in the demand for various live-cell imaging technologies and the high fatality rate associated with CVDs are the major amplifiers of the Live Cell Imaging Market. The major market players in the Global Live cell imaging market are Carl Zeiss AG, Nikon Corporation, Olympus Corporation, PerkinElmer, Inc., Sartorius AG, G.E. Healthcare, Bruker Corporation, Thermo Fisher Scientific Inc., Etaluma Inc., Oxford Instruments, BioTek Instruments, CytoSMART Technologies, Danaher Corporation, NanoEnTek Inc., Phase Focus Limited, Tomocube Inc.

Breast Cancer Liquid Biopsy Market

The vital report on “Breast Cancer Liquid Biopsy Market” Insights & Forecast 2030 published by Strategic Market Research deciphers a detailed understanding of the crucial market insights. The market was valued at 104.42 Million in 2020, and it's forecasted to reach a landmark of up to 604.71 Million by 2030 with a comprehensive CAGR value of 19.2%. Significant factors that are augmenting the market growth are the surge in funding for R&D activities in the field of breast liquid biopsy, favourable initiatives undertaken by governments and global health organizations, and the rise in the approvals of breast cancer liquid biopsy reagents. Some of the vital players operating in the Breast Cancer Liquid Biopsy Market include Johnson & Johnson (Janssen Diagnostics), F. Hoffmann-La Roche Ltd, Qiagen, Janssen, Diagnostics, Guardant Health Inc., Myriad Genetics, Adaptive Biotechnologies, Epic Sciences, Fluxion Biosciences Inc., Biodesix, Illumina Inc., Bio-Rad Laboratories, Biocept Inc,

Recombinant Protein Market

The report on “Recombinant Protein Market” Insights & Forecast 2030 published by Strategic Market Research elaborates a clear undertanding about the key market insights. The total market was valued at 1.5 Billion in 2020, and is likely to augment up to 3.93 Billion by 2030 with a healthy CAGR of 10.12%. The growing need to reduce the frequent occurences of viral illnesses, including human papillomavirus, hepatitis B, CoVid-19, and many others, is the key driver that is fostering the market growth significantly. The most crucial players in the Global Recombinant Protein industry are R&D Systems (US), Abcam plc (UK), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (the US), Proteintech Group, Inc. (the US), Janssen-Cilag Pty Ltd., Aviva Systems Biology, Bio-Techne Corporation (US), Elpiscience BioPharma, Eli Lilly and co., GigaGen Inc.

Protein Expression Market

The report on “Protein Expression Market” Insights & Forecast 2030 published by Strategic Market Research asserts a clear idea regarding the different market insights. The overall market was valued at 2.2 Billion in 2020, and it's anticipated to expand up to 6.47 Bn by the end of the year 2030 with a CAGR of 11.4%. The rising occurrence of target illnesses, greater effectiveness of protein therapies, and surge in the adoption rate are the significant factors that are fostering the market growth. The most vital players in the Global Protein Expression Market are Agilent Technologies Inc., Merck KGaA, Takara Bio Inc, New England Biolabs, GenScript Biotech Corporation, BECTON, DICKINSON AND COMPANY, THERMO FISHER SCIENTIFIC, INC., BIO-RAD LABORATORIES, INC., LifeSensors Inc., Promega Corporation, QIAGEN NV., Oxford Expression Technologies Ltd. and Synthetic Genomics Inc.

Single-use Bioprocessing Market

The vital report on “Single-use Bioprocessing Market” Insights & Forecast 2030 published by Strategic Market Research encompasses a detailed understanding of the various market insights. The market was valued at 12.8 Billion in 2020, and it's poised to grow up to 56 Billion by 2030 with an overall CAGR of 15.86%. The surge in the elderly population, growing demand for biopharmaceuticals, and rising number of biological approvals are the primary drivers of this Single-use Bioprocessing Market. Some of the key players are Catalent, Merck KGaA (Germany), Thermo Fisher Scientific (US), Danaher Corporation (US), Sartorius Stedim Biotech S.A. (France), Getinge AB (Sweden), Eppendorf AG (Germany), Corning (US), Avantor (US), CESCO Bioengineering Co. Ltd. (Taiwan), Entegris (US), Cellexus (UK), Distek, Inc. (US), ABEC, Inc. (US), PBS Biotech, Inc. (US), G&G Technologies (US), take Chemical Equipment Mfg., Ltd. (Japan), Bbi-biotech GmbH (Germany), Pierre Guerin (France), Meissner Filtration Products, Inc. (US), OmniBRx Biotechnologies (India), Kuhner AG (Switzerland), etc.

About Us:
Strategic Market Research facilitates the organizations globally in taking pivotal business decisions by furnishing the Syndicated and Customized Research Reports, which are highly precise in terms of market numbers. We believe that every firm, whether it is a startup that is in the Introduction stage of the Product Life cycle or an established one that is at the growth stage, requires market research services in order to streamline its key business blueprint. It may be related to Product Launch, Go to Market strategies, Competitive Analysis or new geographical penetration and expansion.

Contact Us:
Strategic Market Research LLP.
Sunil Kumar 
US: +1-8317045538
UK: +441256636046
India: +91-8260836500
Email: info@strategicmarketresearch.com
Web: https://www.strategicmarketresearch.com
Blog: https://www.strategicmarketresearch.com/blogs/robotics-industry-statistics
Press Release: https://www.strategicmarketresearch.com/press-releases

Connect Us:
LinkedIn: https://www.linkedin.com/company/strategic-market-research/
Twitter: https://twitter.com/smrstrategic
Facebook: https://www.facebook.com/StrategicMarketResearch
Instagram: https://www.instagram.com/strategicmarketresearchsmr/